SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 492
EU - Europa 206
AS - Asia 37
Totale 735
Nazione #
US - Stati Uniti d'America 492
IT - Italia 57
SE - Svezia 52
IE - Irlanda 47
SG - Singapore 19
UA - Ucraina 19
GB - Regno Unito 13
DE - Germania 10
CN - Cina 7
IN - India 6
FI - Finlandia 4
AT - Austria 2
DK - Danimarca 2
ID - Indonesia 2
VN - Vietnam 2
KR - Corea 1
Totale 735
Città #
Chandler 97
Ashburn 59
Fairfield 48
Dublin 47
Jacksonville 29
New York 28
Lawrence 21
Princeton 21
Houston 18
Turin 17
Seattle 15
Wilmington 14
San Diego 13
Woodbridge 12
Washington 10
Beijing 7
Boardman 7
Cambridge 7
Ann Arbor 6
London 6
San Mateo 6
Macerata 4
Helsinki 3
Des Moines 2
Hanoi 2
Marano di Valpolicella 2
Marche 2
Mountain View 2
Palermo 2
Pune 2
Redwood City 2
Trecate 2
Vienna 2
Casalbordino 1
Chiswick 1
Falkenstein 1
Fayetteville 1
Kilburn 1
Los Angeles 1
Miami Beach 1
San Benedetto del Tronto 1
Southwark 1
Valeggio Sul Mincio 1
Totale 525
Nome #
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 68
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 66
null 62
Role of STAT3 pathway in genitourinary tumors 52
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 51
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 50
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 47
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 41
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 39
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 31
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 29
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 29
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 28
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 26
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 26
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 25
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 24
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 24
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 24
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 21
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 20
Totale 783
Categoria #
all - tutte 6.767
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.767


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 2 2 5 0 5 0 5 3 7 7
2020/2021109 11 7 20 0 9 10 8 10 12 10 10 2
2021/2022142 6 6 4 0 1 4 0 5 35 17 41 23
2022/2023299 21 31 34 14 15 40 1 16 72 1 45 9
2023/2024183 28 5 20 26 30 60 2 9 1 2 0 0
Totale 783